Hans Lilja
71 – 80 of 459
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Androgen deprivation therapy potentiates the efficacy of vascular targeted photodynamic therapy of prostate cancer xenografts
(
- Contribution to journal › Article
- 2017
-
Mark
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer
(
- Contribution to journal › Article
-
Mark
Clinical-Scale Cell-Surface-Marker Independent Acoustic Microfluidic Enrichment of Tumor Cells from Blood
(
- Contribution to journal › Article
-
Mark
Vasectomy and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
(
- Contribution to journal › Article
- 2016
-
Mark
Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections
(
- Contribution to journal › Article
-
Mark
Circulating Tumor Cell Count as an Indicator of Treatment Benefit in Advanced Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice : A microsimulation screening analysis
(
- Contribution to journal › Article
-
Mark
Porous silicon microarray for simultaneous fluorometric immunoassay of the biomarkers prostate-specific antigen and human glandular kallikrein 2
(
- Contribution to journal › Article